Skip to search.
 TSX Up 0.17% TSX Ventures Up 1.33%

Gilead Sciences Inc. (GILD)

-NasdaqGS
72.42 Down 0.42(0.58%) Dec 2, 4:00PM EST
Prev Close:72.84
Open:73.04
Bid:72.35 x 100
Ask:72.45 x 400
1y Target Est:95.74
Beta:0.930345
Earnings Date:Jan 31 - Feb 6 (Est.)
Day's Range:72.16 - 73.60
52wk Range:71.39 - 104.79
Volume:9,227,901
Avg Vol (3m):9,617,610
Market Cap:95.41B
P/E (ttm):6.70
EPS (ttm):10.82
Div & Yield:1.88 (2.55%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.58%95.41B
GSKUp 0.72%93.89B
PFEUp 0.54%191.94B

Key Statistics

Forward P/E (1 yr):6.67
P/S (ttm):3.04
Ex-Dividend Date:14-Sep-16

Analysts

Annual EPS Est (Dec-16) :11.47
Quarterly EPS Est (Dec-16) :2.62
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-9.92

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback